NEW YORK (GenomeWeb News) – A group of federal, academic, and industry partners in the US have launched a new challenge to spur the development of new computational tools for predicting patient responses to certain drugs and chemicals based on their genomes, Sage Bionetworks said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.